Farsang C, Kapocsi J, Varga K, Vajda L, Balás-Eltes A, Kunos G
Acta Physiol Hung. 1985;65(2):217-26.
Analysis of the effect of naloxone (0.4 mg iv.) on clonidine hypotension in 80 patients with essential hypertension revealed that two groups could be separated. In the responding group (43 pts) naloxone increased blood pressure and heart rate in clonidine-treated patients while in the non-responding group (37 pts) it has no such effect. Patients in the responding group had higher cardiac output, stroke volume, plasma renin activity, plasma adrenaline and beta-endorphin levels and lower total peripheral resistance, shorter history of hypertension and lesser body weight than those in the non-responding group. The pressor effect of naloxone in four responding patients treated with clonidine for 29 months tended to be smaller compared to the response obtained after a 3-day clonidine therapy. Results favour the hypothesis of the existence of two (responding, non-responding) groups of patients with essential hypertension. Further work will clarify whether these groups represent different pathogenesis or they indicate only a different stage of hypertension.
对80例原发性高血压患者静脉注射0.4毫克纳洛酮对可乐定所致低血压的影响进行分析后发现,可将患者分为两组。在反应组(43例患者)中,纳洛酮使接受可乐定治疗的患者血压和心率升高,而在无反应组(37例患者)中则无此作用。与无反应组患者相比,反应组患者的心输出量、每搏输出量、血浆肾素活性、血浆肾上腺素和β-内啡肽水平更高,总外周阻力更低,高血压病史更短,体重更轻。与接受3天可乐定治疗后获得的反应相比,在接受可乐定治疗29个月的4例反应患者中,纳洛酮的升压作用趋于较小。结果支持原发性高血压患者存在两组(反应组、无反应组)的假说。进一步的研究将阐明这些组是代表不同的发病机制,还是仅表明高血压的不同阶段。